IDH2 and central nervous system cancer: Although several studies have referred to IDH mutation using M.R. spectroscopy, perfusion, permeability, or chemical exchange saturation transfer imaging, using solely one factor may not suffice for non-contrast-enhanced gliomas [32,33,34,35,36,37].